v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 8,293 $ 6,219
Prepaid expenses, deposits, and other current assets 1,487 328
Total current assets 9,780 6,547
Other assets 724 693
Total assets 10,504 7,240
Current liabilities:    
Accounts payable 3,207 2,353
Accrued expenses and other current liabilities 1,538 1,386
Current portion debt - Cares Act Paycheck Protection Program note payable 200
Senior Secured Convertible Notes - at fair value 15,620 8,139
Senior Convertible Note - at fair value 4,600
Total current liabilities 25,165 11,878
Cares Act Paycheck Protection Program note payable 100
Total liabilities 25,265 11,878
Commitments and contingencies (Note 5)
Stockholders' Equity (Deficit):    
Common stock, $0.001 par value. Authorized, 150,000,000 shares; issued and outstanding, 49,655,915 shares at September 30, 2020 and 40,478,861 shares at December 31, 2019 50 41
Additional paid-in capital 64,050 47,554
Accumulated deficit (79,461) (53,715)
Total PAVmed Inc. Stockholders' Deficit (12,898) (3,824)
Noncontrolling interests (1,863) (814)
Total Stockholders' Equity (Deficit) (14,761) (4,638)
Total Liabilities and Stockholders' Equity (Deficit) 10,504 7,240
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,203,488 at September 30, 2020 and 1,158,209 shares at December 31, 2019 $ 2,463 $ 2,296

Source